Endocan Corporation's Patient Resource Center allows patients to be as open and connected as they wish. The examples presented here are included with the full knowledge and consent of the patient. See the link below.
ENDO recently sold for 15.6 Cents. Its 52 week high was 25 Cents and the low was 1.9 Cents. As of March 23, 2014 the stock sold for 8.55 Cents a Share. As of the time the blog was written, no information was published as to the trading of insiders on this stock.
Endocan Corporation is currently developing new natural products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.
This document in the link above provides dramatic photographic evidence of cannabis extracts curing basal-cell carcinoma via topical application.
This Australian woman had a number of surgeries to remove basal cell carcinoma lesions. She subsequently successfully treated a new lesion appeared on her right cheek with the topical application of cannabis extracts applied daily until her surgeon stated that there was no need for surgery since the lesion on her cheek was gone.
Endocan develops products for critical ailments.
The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.
Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.
Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well.
This section covers the 5 Why's and 1 How about these ailments:
Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference? Explore the company website for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.
See the company website: www.endocan.com
Table: Market Analysis
Market Analysis Chart
Table: Global Potential Customers
Table: Global Potential Customers - Cancer
Forward Looking Statements
This Company Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Endocan Corporation
President
Dr. Dorothy Bray
info@endocan.com This email address is being protected from spambots. You need JavaScript enabled to view it.
www.endocan.com
+1.866.326.5595
What we will do next!
In part 10, we will look at how to create a low cost portfolio of these nine stocks from part 1 thru part 9 for your speculative money making venture.
You may consider contacting family and friends in the hope of starting a stock club, investing in such stocks.
If you are the type of person that can think like a leader instead of a commoner, you may think about starting a stock club with the objective of influencing or taking over a corporation.
Why? To give your family some financial security and power in society.
President
Dr. Dorothy Bray
info@endocan.com This email address is being protected from spambots. You need JavaScript enabled to view it.
www.endocan.com
+1.866.326.5595
What we will do next!
In part 10, we will look at how to create a low cost portfolio of these nine stocks from part 1 thru part 9 for your speculative money making venture.
You may consider contacting family and friends in the hope of starting a stock club, investing in such stocks.
If you are the type of person that can think like a leader instead of a commoner, you may think about starting a stock club with the objective of influencing or taking over a corporation.
Why? To give your family some financial security and power in society.
No comments:
Post a Comment